PRINCIPIA BIOPHARMA INC's ticker is PRNB and the CUSIP is 74257L108. A total of 54 filers reported holding PRINCIPIA BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $345,000 | -19.8% | 5,775 | -20.2% | 0.16% | -7.9% |
| Q1 2020 | $430,000 | -5.1% | 7,235 | -12.6% | 0.18% | +139.2% |
| Q4 2019 | $453,000 | +119.9% | 8,277 | +13.5% | 0.07% | +76.2% |
| Q3 2019 | $206,000 | -19.5% | 7,294 | -5.3% | 0.04% | -22.2% |
| Q2 2019 | $256,000 | -16.9% | 7,700 | -14.9% | 0.05% | -91.8% |
| Q1 2019 | $308,000 | +9.2% | 9,048 | -12.2% | 0.66% | +1264.6% |
| Q4 2018 | $282,000 | – | 10,308 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,996,588 | $56,384,000 | 17.05% |
| Samsara BioCapital, LLC | 383,480 | $10,829,000 | 7.37% |
| Sofinnova Investments, Inc. | 1,417,258 | $40,023,000 | 3.62% |
| Cormorant Asset Management, LP | 1,341,896 | $37,895,000 | 2.31% |
| Orbimed Advisors | 1,605,713 | $45,345,000 | 0.86% |
| Redmile Group, LLC | 790,006 | $22,310,000 | 0.75% |
| PFM Health Sciences, LP | 559,553 | $15,802,000 | 0.47% |
| RTW INVESTMENTS, LP | 270,948 | $7,652,000 | 0.46% |
| Baker Brothers Advisors | 1,654,029 | $46,710,000 | 0.32% |
| UNIVERSITY OF NOTRE DAME DU LAC | 24,572 | $694,000 | 0.21% |